Press release
Acquired Aplastic Anemia Market Key players- Pfizer Inc. (U.S.), Bayer AG (Germany), Novo Nordisk AS (Dernmark) and Shire (Republic of Ireland) Market study and Forecast 2017-2023
Market ScenarioAcquired aplastic anemia is a rare, serious blood disorder, which is characterized by failure of the bone marrow and its inability to produce blood cells. Bone marrow is found in the center of the bones and appears to be like a spongy substance. It is responsible for the production of red blood cells along with other blood components.
Aplastic anemia has two manifestations, i.e. Acquired aplastic anemia and inherit aplastic anemia Acquired aplastic anemia is more common, and sometimes it's only temporary whereas, it is a rare disorder as compared to inherit aplastic anemia. Various causes of acquired aplastic anemia includes toxins, such as pesticides, arsenic, and benzene, radiation and chemotherapy-treatments, infectious diseases, such as hepatitis, Epstein-Barr virus, cytomegalovirus, parvovirus B19, and HIV. And autoimmune disorders, such as lupus and rheumatoid arthritis. Sometimes, cancer from another part of the body can spread to the bone and cause acquired aplastic anemia.
View Reports Sample @ https://www.marketresearchfuture.com/sample_request/4670
The acquired aplastic anemia market growth is majorly attributed to the increasing prevalence of the blood disorders, rising funding, healthcare insurance coverage, and awareness programs for blood disorders.
According to the 2014 Annual Global Survey of the World Federation of Hemophilia (WFH), the total population of Egypt was 86,895,099 out of which 5,246 people were living with hemophilia, 513 were living with Von Willebrand disease, and 1,123 with other blood disorders. It is also reported that 4201 cases of hemophilia A were registered and among them 37% were under 4 years
A research study published in Medicine journal in 2017 stated that hemophilia A is the most common type of hemophilia and most dominant in male patients is 1: 5000 to 10,000. Whereas, the prevalence rate of hemophilia B is 1: 34,500 male patients.
Moreover, advancing technology in medical devices is adding fuel to the growth of the market. Furthermore, increasing prevalence of cancer also drives the market growth.
However, availability of expensive treatment and poor reimbursement policies in the developing regions of the world are some of the factors, which may hamper the market growth during the forecast period.
The global acquired aplastic anemia market is expected to grow at a CAGR of 7.6 % during the forecast period 2017-2023.
Intended Audience
Pharmaceutical Companies
Medical Devices Companies
Research and Development (R&D) Companies
Government Research Institute
Academic Institutes and Universities
Segmentations
The global acquired aplastic anemia market is segmented on the basis of types, by diagnosis, by treatment, and by end user.
On the basis of type, it is segmented into moderate aplastic anemia, severe aplastic anemia, and very severe aplastic anemia.
On the basis of diagnosis, it is segmented into bone marrow biopsy, X-rays, computed tomography (CT) scans, and others.
On the basis of treatment, it is segmented into bone marrow transplantation, immunosuppressive therapies, and others.
On the basis of end user, it is segmented into hospitals & clinics, research centers, and others.
Regional Analysis
The Americas dominate the global acquired aplastic anemia market owing to well-developed technology, increasing patient with blood disorders, increasing prevalence of cancer, high healthcare spending, and increasing government support for research & development. Furthermore, increased R&D activities and the concentration of major companies have fuelled the growth of the market in this region.
Europe holds the second position in the global acquired aplastic anemia market owing to the government support for research & development and availability of funds for research. This is expected to continue to drive the European market over the forecasted period. For instance, countries like Germany and France are increasing investment in the healthcare domain.
Asia Pacific is the fastest growing acquired aplastic anemia market owing to the presence of rapidly developing healthcare technology, huge patient population, and high healthcare expenditure. Moreover, increasing demand for new treatment methods in countries like India and South Korea is likely to emerge as the fastest growing market across the globe. Furthermore, increasing demand for quality devices in the healthcare projected to lead to the use of advanced equipment, which, in turn, will increase the market growth of the acquired aplastic anemia in the region.
On the other hand, in the Middle East and Africa, blood disorders have become a huge problem due to limited screening, ignorance of diseases, and poor access to treatment.
Request Full Report @ https://www.marketresearchfuture.com/reports/acquired-aplastic-anemia-market-4670
Key Players
Some of key the players in the market are Pfizer Inc. (U.S.), Bayer AG (Germany), Novo Nordisk AS (Dernmark), Shire (Republic of Ireland), SOBI (Sweden), Octapharma (Switzerland), CSL Limited (Australia), Amgen Inc., GlaxoSmithKline plc., and Bluebird bio.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Acquired Aplastic Anemia Market Key players- Pfizer Inc. (U.S.), Bayer AG (Germany), Novo Nordisk AS (Dernmark) and Shire (Republic of Ireland) Market study and Forecast 2017-2023 here
News-ID: 1053146 • Views: …
More Releases from Market Research Future

9-Decanoic Acid Methyl Ester Market Poised for Strong 6.59% CAGR Growth Through …
The 9-decanoic acid methyl ester market is a growing sector driven by the increasing demand for bio-based and sustainable chemical products across various industries. With its unique properties, it finds application in flavors and fragrances, pharmaceuticals, personal care, and as a chemical intermediate. The market is projected to expand significantly in the coming years.
Market Overview and Size
The global 9-decanoic acid methyl ester market was valued at USD 230.0 million in…

Washable Marker Market Poised for 3.54% CAGR Growth During 2024-2032
The washable marker market is a dynamic and growing segment within the broader stationery and art supplies industry. Driven by a blend of consumer demands for safety, convenience, and sustainability, the market is experiencing consistent expansion, particularly within the education and home-use sectors. While faced with some challenges, the industry's future looks promising, propelled by product innovation and evolving consumer trends.
Get Sample @ https://www.marketresearchfuture.com/sample_request/41217
Market Size and Growth
The global washable…

Phone Car Mounts Market to Reach USD 7.37 Billion by 2034, Growing at 6.47% CAGR
The phone car mounts market, a critical sub-segment of the broader automotive accessories industry, is experiencing robust growth driven by a convergence of technological advancements, evolving consumer behavior, and increasingly stringent road safety regulations. As smartphones become indispensable for navigation, communication, and in-car entertainment, the demand for secure and convenient hands-free solutions continues to escalate. The global phone car mounts market was valued at USD 3.93 billion in 2024 and…

Intravenous (IV) Solution Market Set to Grow to USD 26.60 Billion at 7.70% CAGR …
Market Overview:
The Intravenous (IV) Solution Market is estimated to be valued at USD 13.9 billion in 2023 and is projected to reach USD 26.60 billion by 2032, expanding at a compound annual growth rate (CAGR) of 7.70% from 2024 to 2031. The market growth is attributed to the rising prevalence of chronic diseases, growing hospitalization rates, and increasing surgical procedures that require IV fluid administration. Intravenous solutions are critical…
More Releases for Acquired
Rising Incidence Of Hospital-Acquired Infections Fuels Growth In Hospital Acquir …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Hospital Acquired Infections Testing Kits Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for kits testing hospital-acquired infections has seen substantial growth in the recent past. The market, currently valued at $4.54 billion in 2024, is projected to expand to $4.83 billion…
Acquired Orphan Blood Disease Market
Acquired Orphan Blood Disease Market to reach over USD 18.93 billion by the year 2031 - Exclusive Report by InsightAce Analytic
According to a new report by InsightAce Analytic, the "Acquired Orphan Blood Disease Market" in terms of revenue was estimated to be worth $8.65 billion in 2023 and is poised to reach $18.93 billion by 2031, growing at a CAGR of 10.47% from 2024 to 2031.
Get Free Access to…
Community-Acquired Bacterial Pneumonia Market
DelveInsight's "Community-Acquired Bacterial Pneumonia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Community-Acquired Bacterial Pneumonia, historical and forecasted epidemiology as well as the Community-Acquired Bacterial Pneumonia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Community-Acquired Bacterial Pneumonia market report provides current treatment practices, emerging drugs, Community-Acquired Bacterial Pneumonia market share of the individual therapies, and current…
Hospital Acquired Disease Testing Market - Enhancing Patient Safety: Comprehensi …
Newark, New Castle, USA: The "Hospital Acquired Disease Testing Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Hospital Acquired Disease Testing Market: https://www.growthplusreports.com/report/hospital-acquired-disease-testing-market/7807
This latest report researches the…
SOS acquired by PracticeEvolve
Solicitors Own Software (SOS) have announced the sale of the business to PracticeEvolve Group to continue to provide the market with progressive technology, supported by strong service and support.
Operating since 1987, SOS have delivered practice and case management software and services to law firms across the UK. With over 17,000 users and a solid client base, Graham Colbourne, Managing Director, says the sale will ensure the market is provided…
Pneumonia Drug Development Market Focuses on Top Players (Hospital Acquired Pneu …
Pneumonia Drug Development Market study provides comprehensive data which enhances the understanding, scope and application of this report. Polyamides, polyethylene, nylons, epoxy resins, polysulfones, polyphthalamides, polyesters, and polycarbonates are some key forms of plastics that are employed in electronic components. The insulation properties of plastic account for its in depth use in electrical and electronic components of machines and gadgets.
Report Consultant has introduced a new report titled as Global Pneumonia…